Stocktwits on MSN
Psyence BioMed Doses Multiple Patients and Expands Clinical Sites in Phase IIb Study for Adjustment Disorder in Palliative Care
Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today ...
An analysis of feldspar crystals within the oldest magmatic rocks in Australia has provided a unique insight into Earth's ...
Psyence Biomedical (PBM) announced a major clinical milestone with multiple patients successfully dosed in its ongoing Phase IIb clinical trial ...
University of Queensland researchers have completed the first comprehensive studies of recent fire history and koala ...
Australia’s rainforests are the first in the world to switch from being a net carbon sink to a net carbon source, according to a news release from Australian National University and a study published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback